Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMQ6CYE)

Drug Name
BIWB-1 Drug Info
Synonyms Melanoma vaccine (autologous), Boehringer Ingelheim/Bender; IL-2 gene therapy (autologous), Boehringer Ingelheim/Bender
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Discontinued in Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMQ6CYE

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interleukin-2 (IL2) TTF89GD IL2_HUMAN Not Available [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Interleukin-2 (IL2) DTT IL2 0.848 4.548 3.548 4.053
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Melanoma
ICD Disease Classification 2C30
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interleukin-2 (IL2) DTT IL2 7.64E-01 1.04E-02 0.07
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004906)
2 WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting.